Related Experiment Video

Updated: Jul 6, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple

A Curioni-Fontecedro, A J Knights, M Tinguely

    Leukemia
    |March 8, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

    Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

    Published on: September 15, 2023

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.